Erste Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.3M | Buy |
516,663
+229,053
| +80% | +$24.5M | 0.46% | 51 |
|
|
2025
Q1 | $28.9M | Buy |
287,610
+47,756
| +20% | +$4.8M | 0.37% | 69 |
|
|
2024
Q4 | $21.7M | Sell |
239,854
-19,244
| -7% | -$1.74M | 0.27% | 94 |
|
|
2024
Q3 | $21.6M | Buy |
259,098
+13,460
| +5% | +$1.12M | 0.26% | 92 |
|
|
2024
Q2 | $18.9M | Buy |
245,638
+13,658
| +6% | +$1.05M | 0.25% | 95 |
|
|
2024
Q1 | $15.9M | Sell |
231,980
-50,251
| -18% | -$3.45M | 0.22% | 115 |
|
|
2023
Q4 | $16M | Sell |
282,231
-46,263
| -14% | -$2.62M | 0.23% | 111 |
|
|
2023
Q3 | $17.5M | Sell |
328,494
-9,000
| -3% | -$480K | 0.3% | 97 |
|
|
2023
Q2 | $18M | Buy |
337,494
+60,189
| +22% | +$3.22M | 0.32% | 86 |
|
|
2023
Q1 | $13.8M | Buy |
277,305
+267,000
| +2,591% | +$13.2M | 0.26% | 108 |
|
|
2022
Q4 | $478K | Sell |
10,305
-18,850
| -65% | -$874K | 0.01% | 428 |
|
|
2022
Q3 | $1.15M | Buy |
29,155
+2,400
| +9% | +$94.4K | 0.03% | 337 |
|
|
2022
Q2 | $1.01M | Buy |
+26,755
| New | +$1.01M | 0.02% | 351 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 600 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 581 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 563 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 564 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 553 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 540 |
|
|
2020
Q3 | – | Sell |
-6,990
| Closed | -$242K | – | 496 |
|
|
2020
Q2 | $242K | Sell |
6,990
-210
| -3% | -$7.28K | 0.01% | 371 |
|
|
2020
Q1 | $228K | Hold |
7,200
| – | – | 0.01% | 345 |
|
|
2019
Q4 | $326K | Buy |
+7,200
| New | +$326K | 0.01% | 341 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 478 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 487 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 476 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 495 |
|